Martin v. Actavis, et al.: Represented Actavis, Inc. (n/k/a Allergan) in successful defense of litigation alleging injuries from Androderm®, a testosterone replacement therapy (TRT) drug. In August 2021, after less than one hour of deliberation, a seven-person jury returned a unanimous defense verdict following a two-week trial.
